Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10221126 Solabegron zwitterion and uses thereof

Patent 10221126 was granted and assigned to Velicept Therapeutics on March, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+471 characters)
Article

Patent abstract

This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Bingidimi Itute Mobele0
Dalian Zhao0
Raymond E. Stevens0
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 30 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 6 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Feb, 2022
Edits on 3 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10668034 Pharmaceutical compositions and the treatment of overactive bladder
Edits on 27 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10350182 Pharmaceutical compositions and the treatment of overactive bladder
Edits on 25 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 25 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10221126 Solabegron zwitterion and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
‌
Velicept Therapeutics
Current assignee
‌
Velicept Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10221126
Date of patent
March 5, 2019
Patent application number
16018945
Date Filed
June 26, 2018
Patent primary examiner
‌
Nyeemah A Grazier

Find more entities like US Patent 10221126 Solabegron zwitterion and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo